• Press Release

  Genesis Biotechnology Group Acquires BioBlocks to Grow the Preclinical Chemistry Services Portfolio of Genesis Drug Discovery & Development (GD³)

  10/2021
• Press Release

  Genesis Drug Discovery & Development Appoints Anthony Rohr as Chief Operating Officer

  9/2021
• Press Release

  Genesis Drug Discovery & Development Appoints Laura Sailor Veteran CRO Business Development Leader as Director of Business Development

  9/2021
• Press Release

  Genesis Drug Discovery and Development acquires Integrated Analytical Solutions to add "off the shelf" PK profiling capabilities to its portfolio.

  3/2021
• Press Release

  Genesis Drug Discovery and Development expands its presence in the clinical space by acquiring STATKING Clinical Services

  1/2021
• Press Release

  Genesis Biotechnology Group announces second year of CRO relationship with Yale University

  12/2020
• Press Release

  Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services

  8/2020
• Press Release

  Genesis Drug Discovery & Development (GD3) Announces Appointment of Anthony Rohr, as Chief Executive Officer of PharmOptima.

  8/2020
• Press Release

  Genesis Biotechnology Group acquires NEDP to grow the Preclinical Chemistry services portfolio of Genesis Drug Discovery & Development

  11/2019
• Press Release

  Genesis Drug Discovery & Development Expands Preclinical Contract Research Portfolio by Acquiring NexusPharma.

  6/2019
• Press Release

  Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS, Inc.

  2/2019
• Press Release

  Genesis Biotechnology Group announces partnership with Yale University

  10/2018
• Press Release

  Genesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptima

  3/2017